Results 121 to 130 of about 5,671,728 (318)

CORPORATE UNIVERSITY DEVELOPMENT

open access: yesEconomic Analysis, 2019
Introduction. Corporate University is an educational entity which helps to advance organizational and individual knowledge. It has been widely discussed and adopted by many organizations. We investigate the development of corporate learning within the context of corporate universities. We determine that the corporate university meets business needs in
openaire   +2 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

CSR and Social Marketing: What is the desired role for Universities in fostering Public Policies? [PDF]

open access: yes
The paper aims to identify the role of Universities in fostering public policies, through the promotion of social responsibility, and the implementation of social marketing initiatives.
Leitão, João, Silva, Maria José
core   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

A Crisis of Mistaken Identity: The Ethical Insufficiency of the Corporate University Model

open access: yesJournal of Moral Theology, 2020
Today, universities and their administrators increasingly see themselves through the eyes of a corporate university model that defines the university as a business and asserts that it is best understood in strictly economic terms.
Conor M. Kelly
doaj  

Proposed model of corporate University

open access: yesVisión de Futuro, 2019
In this review article, we first address the antecedents, trying to identify which were the first corporate universities, then an approach to the definition of the concept of corporate university is proposed and the definition that will orient the document, result of the revision a proposal for a model of Corporate University shows the relationship ...
openaire   +3 more sources

Corporate Social Responsbility in Business Courses: How Can Generation Y Learn? [PDF]

open access: yes, 2008
This paper deals with the teaching of Corporate Social Responsibility (CSR) in Business courses to Generation Y Business students in Australian universities.
Gleeson, Damian, Heaney, Joo-Gim
core   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Educational Policies for Integrating College Competencies and Workforce Needs [PDF]

open access: yes, 2009
Explores the challenges of workforce development for a global economy in Brazil, Mongolia, Ukraine, and the United States, with a focus on basic skills development, internships, and the role of stakeholders.

core  

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy